Journal Title：Molecular Cancer Research

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.

《分子癌癥研究》發表的文章描述了該領域廣泛關注的新型基礎癌癥研究發現。研究必須具有顯著意義，該期刊優先考慮在分子和細胞水平上進行的分析，這些分析揭示了與癌癥風險、發展和/或進展相關的途徑和過程的新機制見解。重點領域包括所有與癌癥相關的途徑（包括細胞周期調控；細胞死亡；染色質調控；DNA 損傷和修復；基因和 RNA 調控；基因組學；致癌基因和腫瘤抑制因子；信號轉導；以及腫瘤微環境），以及描述支持癌癥表型的新分子機制和相互作用的研究。為了獲得充分考慮，主要研究提交必須提供對現有途徑功能的重大新見解或解決與癌癥相關的生物學問題相關的新假設。

Molecular Cancer Research創刊于2002年，由American Association for Cancer Research Inc.出版商出版，收稿方向涵蓋醫學 - 細胞生物學全領域，此刊是該細分領域中屬于非常不錯的SCI期刊，在行業細分領域中學術影響力較大，專業度認可很高，所以對原創文章要求創新性較高，如果您的文章質量很高，可以嘗試。平均審稿速度 偏慢,4-8周 ，影響因子指數4.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。